Targeting transcription factors in cancer drug discovery
Cancer drug discovery is currently dominated by clinical trials or clinical research. Several potential drug candidates have been brought into the pipeline of drug discovery after showing very promising results at the pre-clinical level and are waiting to be tested in human clinical trials. Interest...
Main Author: | Partha Mitra |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2020-12-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/100225 |
Similar Items
-
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
by: Jeroen Overman, et al.
Published: (2017-01-01) -
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
by: Mehdi Moustaqil, et al.
Published: (2020-03-01) -
Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
by: Massimiliano Meli, et al.
Published: (2021-03-01) -
Targeting Transcription Factors for Cancer Treatment
by: Mélanie Lambert, et al.
Published: (2018-06-01) -
Solution NMR Spectroscopy in Target-Based Drug Discovery
by: Yan Li, et al.
Published: (2017-08-01)